Singlet oxygen enhances intrinsic thrombolysis: The intrinsic oxidative clot lysis assay (INOXCLA)

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 4, 2007, Pages 369-383

  Stief, Thomas W ^a,b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Clinical chemistry; Excited nonradical oxygen; Fibrinolysis; Granulocytes; Singlet oxygen; Urokinase

Indexed keywords

SINGLET OXYGEN; TOSYLCHLORAMIDE SODIUM; UROKINASE; CHLORAMINE DERIVATIVE; CHLORAMINE-T; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; OXIDATION; PRIORITY JOURNAL; PROTHROMBIN TIME; BLOOD; DRUG EFFECT; FIBRINOLYSIS; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

CHLORAMINES; FIBRINOGEN; FIBRINOLYSIS; HUMANS; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; SINGLET OXYGEN; TOSYL COMPOUNDS; URINARY PLASMINOGEN ACTIVATOR;

EID: 35748935859     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607306594     Document Type: Article

References (45)

1. Moroz LA, Sniderman AD, Marpole Dgf. Leucocyte-plasma interactions in fibrinolysis. N Engl J Med 1979 ; 301: 1100.
2. van Giezen JJ, Chung A. Hing JE, Vegter CB, Bouma NN, Jansen JW Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. Thromb Haemost 1994 ; 72: 887.
3. Stief TW, Fareed J. The antithrombotic factor singlet oxygen/light (1O2/hν). Clin Appl Thromb Hemost 2000 ; 6: 22.
4. Moir E., Booth NA, Bennett B., Robbie LA Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism. Br J Haematol 2001 ; 113: 72.
5. Stief TW The physiology and pharmacology of singlet oxygen. Med Hypoth 2003 ; 60: 567.
6. Ichinose A., Fujikawa K., Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986 ; 261: 3486.
7. Schott D., Dempfle CE, Beck P., et al. Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med 1998 ; 339: 1679.
8. Cao D., Mizukami IF, Garni-Wagner BA, et al. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 1995 ; 154: 1817.
9. Mao Y., Zang L., Shi X. Singlet oxygen generation in the superoxide reaction. Biochem Mol Biol Int 1995 ; 36: 227.
10. Tarr M., Valenzeno DP Singlet oxygen: The relevance of extracellular production mechanisms to oxidative stress in vivo. Photochem Photobiol Sci 2003 ; 2: 355.
11. Foote CS, Shook FC, Abakerli RB Characterization of singlet oxygen. Methods Enzymol 1984 ; 105: 36.
12. Stief TW The blood fibrinolysis/deep-sea analogy: A hypothesis on the cell signals singlet oxygen/photons as natural antithrombotics. Thromb Res 2000 ; 99: 1.
13. Rosen H., Klebanoff SJ Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 1977 ; 252: 4803.
14. Tatsuzawa H., Maruyama T., Hori K., Sano Y., Nakano M. Singlet oxygen ((1)Delta(g)O(2)) as the principal oxidant in myeloperoxidase-mediated bacterial killing in neutrophil phagosome. Biochem Biophys Res Commun 1999 ; 262: 647.
15. Kiryu C., Makiuchi M., Miyazaki J., Fujinaga T., Kakinuma K. Physiological production of singlet oxygen in the myeloperoxidase-H202-chloride system. FEBS Lett 1999 ; 443: 154.
16. Babior BM Oxidants from phagocytes: Agents of defense and destruction. Blood 1984 ; 64: 959.
17. Stief TW, Hinz F., Kurz J., Doss MO, Kretschmer V. A simple screening assay for certain fibrinolysis parameters (FIPA). Thromb Res 2000 ; 97: 231.
18. Stief TW, Stief MH, Ehrenthal W., Darius M., Martin E. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single-chain urokinase. Thromb Res 1991 ; 64: 597.
19. Dano K., Reich E. Plasminogen activator from cells transformed by an oncogenic virus: Inhibitors of the activation reaction. Biochim Biophys Acta 1979 ; 566: 138.
20. Stief TW, Weippert M., Kretschmer V., Renz H. Arginine inhibits hemostasis activation. Thromb Res 2001 ; 104: 265.
21. Collen D., Lijnen HR The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 1986 ; 4: 249.
22. Lawrence DA, Loskutoff DJ Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 1986 ; 25: 6351.
23. Stief TW, Lenz P., Becker U., Heimburger N. Determination of plasminogen activator (PAI) capacity of human plasma in presence of oxidants: A novel principle. Thromb Res 1988 ; 50: 559.
24. Kanofsky JR Quenching of singlet oxygen by human plasma. Photochem Photobiol 1990 ; 51: 299.
25. Wagner JR, Motchnik PA, Stocker R., Sies H., Ames BN The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. J Biol Chem 1993 ; 268: 18502.
26. Weiss SJ Tissue destruction by neutrophils. N Engl J Med 1989 ; 320: 365.
27. Di Mascio P, Bechara EJ, Medeiros MH, Briviba K., Sies H. Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett 1994 ; 355: 287.
28. Salvemini D., DeNucci RJ, Gryglewski RJ, Vane JR Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc Natl Acad Sci USA 1989 ; 86: 6328.
29. Stief TW, Kurz J., Doss MO, Fareed J. Singlet oxygen (1O2) inactivates fibrinogen, Factor V, Factor VIII, Factor X and platelet aggregation of human blood. Thromb Res 2000 ; 97: 231.
30. Stief TW, Feek U., Ramaswamy A., Kretschmer V., Renz H., Fareed J. Singlet oxygen (1O2) disrupts platelet aggregates. Thromb Res 2001 ; 104: 361.
31. Stief TW Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin. Blood Coagul Fibrinolysis 1993 ; 4: 117.
32. Downey JM, Omar B., Ooiwa H., McCord J. Superoxide dismutase therapy for myocardial infarction. Free Radic Res Commun 1991 ; 12-13: 703.
33. McCord JM Superoxide radical: Controversies, contradictions, and paradoxes. Proc Soc Exp Biol Med 1995 ; 209: 112.
34. Toufektsian MC, Morel S., Tanguy S., Jeunet A., De Leiris J, Boucher F. Involvement of reactive oxygen species in cardiac preconditioning rats. Antioxid Redox Signal 2003 ; 5: 115.
35. Swiatkowska M., Szemraj J., Al-Nedawi KN, Pawlowska Z. Reactive oxygen species upregulate expression of PAI-1 in endothelial cells. Cell Mol Biol Lett 2002 ; 7: 1065.
36. Babior BM NADPH-oxidase: an update. Blood 1999 ; 93: 1464.
37. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002 ; 397: 342.
38. Brennan ML, Anderson MM, Shih DM, et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001 ; 107: 419.
39. Ruf A., Schlenk RF, Maras A., Morgenstern E., Patscheke H. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood 1992 ; 80: 1238.
40. Kirchhofer D., Riederer MA, Baumgartner HR Specific accumulation of circulating monocytes and polymorphonuclear leucocytes on platelet thrombi in a vascular injury model. Blood 1997 ; 89: 1270.
41. Shappell SB, Toman C., Anderson DC, Taylor AA, Smith CW Adherence-dependent neutrophil hydrogen peroxide secretion is mediated by Mac-1 (CD11b/18). J Immunol 1989 ; 144: 2702.
42. Weiss SJ, Lampert MB, Test ST Long-lived oxidants generated by human neutrophils: Characterization and bioactivity. Science 1983 ; 222: 625.
43. Simon DI, Ezratty AM, Francis SA, Rennke H., Loscalzo J. Fibrinogen is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): A non-plasmin fibrinolytic pathway. Blood 1993 ; 82: 2414.
44. Rubel C., Gómez S., Fernández GC, Isturiz MA, Caamano J., Palermo MS Fibrinogen-CD11b/CD18 interaction activates the NF-KB pathway and delays apoptosis in human neutrophils. Eur J Immunol 2003 ; 33: 1429.
45. Klotz LO, Kroncke KD, Sies H. Singlet oxygen-induced signaling effects in mammalian cells. Photochem Photobiol Sci 2003 ; 2: 88.